The economic importance of innovative activity brings with it an active debate on the effect of public policy on the innovation process. This annual series, sponsored by the National Bureau of Economic Research, brings the work of leading academic researchers to the broader policy community, presenting papers that demonstrate the role that economic theory and empirical analysis can play in evaluating policy. Volume 7 considers such topics as the apparent productivity decline in the pharmaceutical industry; the effect of patents on both the "scientific commons" and cumulative discovery; the flow of new Ph.D.s into industry; a new mechanism to create economic incentives for producers of digital goods that both stimulates innovation and encourages widespread use; and a formal analytical structure for a science of crisis management.

Technical innovation has moved to center stage in contemporary debates on economic theory and policy, and Chris Freeman and Luc Soete have played a prominent part in these debates. For this new edition of The Economics of Industrial Innovation, they have rewritten all the existing chapters and added ten new ones that address recent advances in theory and in policymaking. In the new chapters they deal with the international dimensions of technical change including underdevelopment, technology transfer, international trade, and globalization. They have also strengthened the historical account of the rise of new technologies, a main feature of earlier editions. They take advantage of their experience on projects for the OECD, the European Union, and industry in other new chapters on "The Information Society" and on environmental issues, as well as in the updated discussion of science and technology policy.

Traditional growth theory emphasizes the incentives for capital accumulation rather than technological progress. Innovation is treated as an exogenous process or a by-product of investment in machinery and equipment. Grossman and Helpman develop a unique approach in which innovation is viewed as a deliberate outgrowth of investments in industrial research by forward-looking, profit-seeking agents.

Gene M. Grossman is Professor of Economics and International Affairs at Princeton University. Elhanan Helpman is Archie Sherman Professor of International Economic Relations at Tel Aviv University.

This edition of the bestselling technology guide for executives-from one of the preeminent experts in the field-now expanded to cover all the new and exciting developments on the Internet. The book allows the reader to get inside the mind of industry leader Charles Wang, who shares his vision, a vision that sparked the creation of a $4-billion software development firm, Computer Associates International, Inc. Filled with new case studies, tips, and insights, this edition explores how the World Wide Web is transforming commerce and business. The result is a resource that prepares decision-makers to not only understand the cyber-revolution, but profit from it.

The Financial Principles Every Venture Capitalist Needs To Master

In Andrew Metrick’s Venture Capital and the Finance of Innovation,future and current venture capitalists will find a useful guide to the principles of finance and the financial models that underlie venture capital decisions. Assuming no knowledge beyond concepts covered in first-year MBA course, the book will familiarize you with: The relationship between risk and return in venture capitalHistorical statistics on the performance of venture capital investmentsTotal Valuation - the data and methods used to value a high-growth companyPartial Valuation – how to analyze the special features of VC transactions such as convertible preferred stock, participating preferred stock, payment-in-kind dividends, and liquidation preferencesA framework for modeling investment in "research and development"The relationship between strategy and financeCutting-edge techniques such as Monte-Carlo analysis, real options, binomial trees, and game theory

About the Author:

Andrew Metrick is an Associate Professor of Finance at the Wharton School of the University of Pennsylvania, where he teaches Venture Capital and the Finance of Innovation. Dr. Metrick received a BA in Economics and Mathematics from Yale and a Ph.D. in Economics from Harvard. Dr. Metrick has received numerous teaching awards and distinctions, including recognition by BusinessWeekas one of the best teachers at Wharton.

"This book is an excellent bridge between finance theory and venture capital practice. Metrick presents cutting-edge financial tools, creatively apllied to venture capital and R&D investing. It is destined to become the required reading for all students and practitioners in the field."
—Paul A. Gompers, Eugene Holman Professor of Business Administration & Director of Research, Harvard Business School

"Despite the increasing importance of the venture capital industry, until now there was no reference that could provide practitioners with a specialized grounding in finance. With clear explanations and practical models, Metrick’s book can fill this gap. I enthusiastically recommend this book to all venture capitalists."
—Ted Schlein, Partner, Kleiner Perkins Caufield & Byers

"Investors in young, fast-growing companies have a new way to calculate their value without regard to the prices of other companies’ stocks. This is an important advance, because most other appraisal methods for start-ups are based on relative valuation, which – as we saw at the top of the Internet bubble – grossly overvalues a new company when comparable companies in the same industry are also overvalued."
—Mark Hulbert, The New York Times, Dec. 31, 2006

Innovation and technological change, long recognized as the main drivers of long-term economic growth, are elusive notions that are difficult to conceptualize and even harder to measure in a consistent, systematic way. This book demonstrates the usefulness of patents and citations data as a window on the process of technological change and as a powerful tool for research on the economics of innovation. Patent records contain a wealth of information, including the inventors' identity, location, and employer, as well as the technological field of the invention. Patents also contain citation references to previous patents, which allow one to trace links across inventions.

The book lays out the conceptual foundations for such research and provides a range of interesting applications, such as examining the geographic pattern of knowledge spillovers and evaluating the impact of university and government patenting. It also describes statistical tools designed to handle methodological problems raised by the patent and citation processes. The book includes a CD with complete data on 3 million patents with more than 16 million citations and a range of author-devised measures of the importance, generality, and originality of patented innovations.

This annual series, sponsored by the National Bureau of Economic Research, provides a forum for research on the interactions among public policy, the innovation process, and the economy. Discussions cover all types of policy that affect the ability of an economy to achieve scientific and technological progress or that affect the impact of science and technology on economic growth.

Widely regarded as the most innovative, successful biotech firm ever, Amgen led its industry in revenue and sales growth in 2007. Top magazines including Fortune and Industry Week have repeatedly named it one of America's best companies to work for.

In Science Lessons, Gordon Binder—CEO and chairman during 1988-2000—describes Amgen's climb to success. Revealing the highs and lows it experienced in the race to develop blockbuster drugs, he takes readers from the time Amgen had just three months of capital in the bank and no viable products in the pipeline to its spectacular success. The turning point? The 1989 launch of Epogen, which dramatically helped kidney dialysis patients suffering from debilitating anemia. Other landmark drugs, including Neupogen, would follow. 

Through engaging anecdotes and cogent insights, Binder weaves a fascinating tale while offering his unique brand of practical management advice. Using the principals of the scientific method, he shares his recommendations for tackling pressing business challenges—such as managing creative employees, navigating the IPO process, and protecting intellectual property.

This colorful first-person account showcases the visionary science and daring business strategy that made Amgen great—offering valuable lessons for all companies.

In Mastering the Dynamics of Innovation, Utterback presents a compelling book at how innovation transforms industries, raising the fortunes of some firms while destroying others. The book draws on the rich history of innovation by inventors and entrepreneurs-ranging from the birth of typewriters to the emergence of personal computer, gas lamps to fluorescent lighting, George Eastman's amateur photography to electronic imaging-to develop a practical model for how innovation enters an industry, how mainstream firms typically respond, and how-over time-new and old players wrestle for dominance.

The most comprehensive career book series available, Opportunities In...explores a vast range of professions to help job seekers find the job that's best for them. Each book offers: The latest information on a field of interestTraining and education requirements for each careerUp-to-date professional and internet resourcesSalary statistics for different positions within each fieldAnd much more

How did Microsoft decide what technologies to use when it created Windows95? According to this groundbreaking new book, it is technology integration-the process of choosing from a rich palette of technologies those that will make a product work seamlessly and reliably-that is a critical element to launching successful new products. The result of a six-year study of the major players in the computer industry-including Intel, IBM, Microsoft, Netscape, Silicon Graphics, Sun Microsystems, and Toshiba-the book illustrates the process of technology integration at the managerial and strategic levels and reveals the significant evolution in the structure of research and development in the modern corporation. Iansiti demonstrates convincingly that the ability to leverage new science and technology effectively is inextricably linked to the firm's ability to imagine how a multitude of emerging technological possibilities can be used to define a product that makes business sense. Technology Integration challenges the way traditional R&D organizations should work and provides a new and relevant framework for actively managing the space between the creation and the application of technology. The Management of Innovation and Change Series.